Goodness Growth Holdings Launches Full Line of Cannabis Flower in Minnesota

Goodness Growth Holdings, Inc. ("Goodness Growth" or the "Company") (CSE: GDNS; OTCQX: GDNSF), a physician-led, science-focused cannabis company and IP developer, today announced that its Minnesota operating subsidiary, Vireo Health of Minnesota LLC, has launched a full line of cannabis flower in Minnesota's medical cannabis program. The launch of cannabis flower is in accordance with Minnesota's new regulations allowing certified medical cannabis patients in the state to purchase cannabis in its natural form, as dried whole flower.

Governor Tim Walz signed the legislation to allow cannabis flower sales on May 26, 2021 . The new law will greatly improve Minnesotans' access to natural, affordable cannabis flower that is state-tested and safer than cannabis flower purchased from the illicit market.

"We applaud Gov. Walz, the Minnesota State Legislature, and the Office of Medical Cannabis for its decision to allow flower sales to certified cannabis patients in Minnesota ," said Chairman and Chief Executive Officer, Dr. Kyle Kingsley . "Allowing the sale of cannabis flower will greatly benefit existing patients, bring new patients into the program, and ensure the continued viability of Minnesota's medical cannabis program. Flower sales will reduce the cost of medication for many patients, while also significantly increasing product optionality and diversity."

At launch, the Company will have a wide variety of strains and product formats at all eight of its Green Goods® dispensaries in Minnesota . Select strains will also be available for purchase at all other registered medical cannabis dispensaries in the state to help ensure that all Minnesotans have access to a wide variety of cannabis flower strains. Green Goods will continue to make new strains available for patients throughout the year.

Minnesota's medical cannabis patients have already shown a positive response to these new regulations. To purchase cannabis flower, patients are required to set up a consult with a certified pharmacist at a registered medical dispensary. Over 2,000 patients scheduled consults on the very first day consults were made available, with thousands more setting up consults during the month of February.

Find more details and the full Green Goods menu at https://visitgreengoods.com/mn/ .

About Goodness Growth Holdings, Inc.

Goodness Growth Holdings, Inc., is a physician-led, science-focused holding company whose mission is to bring the power of plants to the world. The Company's operations consist primarily of its multi-state cannabis company subsidiary, Vireo Health, Inc., and its science and intellectual property incubator, Resurgent Biosciences, Inc. The Company manufactures proprietary, branded cannabis products in environmentally friendly facilities and state-of-the-art cultivation sites and distributes its products through its growing network of Green Goods® and other retail locations and third-party dispensaries. Its teams of more than 500 employees are focused on the development of differentiated products, driving scientific innovation of plant-based medicines, and developing meaningful intellectual property. Today, the Company is licensed to grow, process, and/or distribute cannabis in eight markets and operates 18 dispensaries across the United States . For more information about Goodness Growth Holdings, please visit www.goodnessgrowth.com .

Contact Information
Investor Inquiries:
Sam Gibbons
Vice President, Investor Relations
samgibbons@goodnessgrowth.com
(612) 314-8995

Media Inquiries:
Albe Zakes
Vice President, Corporate Communications
albezakes@goodnessgrowth.com
(267) 221-4800

Cision View original content to download multimedia: https://www.prnewswire.com/news-releases/goodness-growth-holdings-launches-full-line-of-cannabis-flower-in-minnesota-301491066.html

SOURCE Goodness Growth Holdings, Inc.

News Provided by PR Newswire via QuoteMedia

CNX:GDNS,GDNSF
The Conversation (0)
Cannabis plant in focus, blurred US flag background.

Analysts React: Trump Signs Executive Order to Reschedule Cannabis

The long-debated issue of US cannabis rescheduling is finally back in the spotlight. On Thursday (December 18), President Donald Trump signed an executive order to expedite the process of moving cannabis from Schedule I to Schedule III under the Controlled Substances Act. Market watchers are now... Keep Reading...
Close-up of green cannabis leaves in natural light.

Trump Weighs Executive Order to Loosen Federal Cannabis Restrictions

US President Donald Trump is reportedly weighing a major shift in federal drug policy that would relax decades-old restrictions on cannabis, potentially injecting new life into the industry. Six people familiar with the discussions told the Washington Post that Trump is preparing an executive... Keep Reading...
Gavel on a surface with scattered cannabis leaves, symbolizing legal issues around marijuana.

Hemp THC Recriminalization: A Blow to a Blooming Industry

A spending bill to reopen the US government after a 43 day shutdown includes provisions that will recriminalize most hemp-derived THC products. This change, slated to become effective one year after enactment, in late 2026, marks a significant policy reversal from the 2018 Farm Bill, which... Keep Reading...
Cannabis buds on a wooden surface with Australian banknotes nearby.

Australia's Cannabis Import Quota Slashed Amid Surging Local Production

Australia’s Office of Drug Control (ODC) said the country’s 2025 cannabis import quota has been reduced by the International Narcotics Control Board from 101 tonnes to 88 tonnes, Business of Cannabis reported.Over-projected demand and idle permits that limited operational flexibility were cited... Keep Reading...
Gavel resting on cannabis leaves.

Cannabis Crossroads: Record US Demand Meets Federal Gridlock

The US cannabis industry is at a turning point. State-level legalization and retail growth continue to accelerate, but federal policy remains stalled, leaving businesses navigating both opportunity and uncertainty. Record consumer demand is driving sales, yet outdated regulations, restrictive... Keep Reading...
Cannabis leaf.

10 Biggest Cannabis Stocks in the US and Canada in 2025

After initial optimism for rescheduling in the US, the cannabis market has faced challenges in 2025. Despite signs of support from US President Donald Trump and members of his administration, regulatory uncertainty persists in the US. Companies are shifting focus to match changes in consumer... Keep Reading...

Interactive Chart

Latest Press Releases

Related News